PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
Federal · 119th Congress

S1551 No Subsidies for Gender Transition Procedures Act

Direction

Transgender healthcareAI label

Restricts transgender recognition & access model confidence 95%

Prohibits federal tax deductions, Medicaid, CHIP, Medicare, and essential health benefits coverage for gender transition procedures (with narrow medical exceptions), so less access to and funding for such care.

The term `medical care' does not include any gender transition procedure.

✓ Quote verified word for word in the bill text

Transgender otherAI label

Restricts transgender recognition & access model confidence 80%

Defines 'sex', 'female', and 'male' strictly by biological function at conception for purposes of the funding bans, narrowing legal recognition of gender identity in this context.

The term `sex', when referring to an individual's sex, means either male or female, as biologically determined.

✓ Quote verified word for word in the bill text

  1. Introduced (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. President
  6. Law

Stage: Committee · step 2 of 6

Last action
2025-05-01: Read twice and referred to the Committee on Finance.
Filed
2025-05-01
Committee
Finance Committee
Sponsor
Roger Marshall R + 4 cosponsors (4 R)

Why the model tagged it this way: The bill substantively addresses transgender healthcare by banning federal subsidies, tax deductions, and public insurance coverage for gender transition procedures (hormonal, surgical, puberty blockers) while carving out narrow exceptions for disorders of sex development, precocious puberty treatment, and reversal procedures. It also defines sex biologically in statute, which is a transgender/other provision. No other listed topics are substantively addressed.

Related bills

Sponsors

Text versions

History (2 actions)
DateChamberAction
2025-05-01LibraIntroduced in Senate
2025-05-01SenatRead twice and referred to the Committee on Finance.